8-K//Current report
Rasna Therapeutics Inc. 8-K
Accession 0001213900-23-004391
CIK 0001582249operating
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 1:31 PM ET
Size
838.1 KB
Accession
0001213900-23-004391
Documents
- 8-Kea172062-8k_rasnatherap.htmPrimary
CURRENT REPORT
- EX-3.1ea172062ex3-1_rasnatherap.htm
CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION OF RASNA THERAPEUTICS, INC
- GRAPHICex3-1_001.jpg
GRAPHIC
- GRAPHICex3-1_002.jpg
GRAPHIC
- EX-101.SCHrasp-20230120.xsd
XBRL SCHEMA FILE
- EX-101.LABrasp-20230120_lab.xml
XBRL LABEL FILE
- EX-101.PRErasp-20230120_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLea172062-8k_rasnatherap_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-23-004391-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
ACTAVIA LIFE SCIENCES, INC.
CIK 0001582249
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001582249
Filing Metadata
- Form type
- 8-K
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 1:31 PM ET
- Size
- 838.1 KB